Table 2.
Primary indication for referral to management of obesity with intensive behavioral therapy (IBT).
Covariate | IP (n = 62) | TM (n = 77) | P-value | IP with ≥2 visits (n = 45) | TM with ≥2 visits (n = 62) | P-value |
---|---|---|---|---|---|---|
Primary indication for referral to IBT program | ||||||
Chronic back pain | 2 (3.2) | 0 (0) | 0.826 | 1 (2.2) | 0 (0) | 0.238 |
Chronic cephalea | 2 (3.2) | 0 (0) | 0.826 | 2 (4.4) | 0 (0) | 0.094 |
Chronic heart failure | 1 (1.6) | 1 (1.3) | 0.877 | 1 (2.2) | 1 (1.6) | 0.818 |
Degenerative disc disease | 1 (1.6) | 5 (6.5) | 0.159 | 1 (2.2) | 5 (8.1) | 0.195 |
Prediabetes or diabetes mellitus | 7 (11.3) | 9 (11.7) | 0.942 | 4 (8.9) | 9 (14.5) | 0.379 |
GERD/HH | 13 (21) | 27 (35.1) | 0.069 | 13 (28.9) | 17 (27.4) | 0.867 |
Hyperlipidemia | 0 (0) | 4 (5.2) | 0.069 | 0 (0) | 4 (6.5) | 0.082 |
Hypertension | 6 (9.7) | 3 (3.9) | 0.169 | 5 (11.1) | 3 (4.8) | 0.223 |
Incisional hernia | 1 (1.6) | 2 (2.6) | 0.702 | 1 (2.2) | 2 (3.2) | 0.756 |
Obesity | 7 (11.3) | 12 (15.6) | 0.463 | 4 (8.9) | 9 (14.5) | 0.379 |
Other conditions | 5 (8) | 7 (9.1) | 0.830 | 3 (6.7) | 6 (9.7) | 0.579 |
Other endocrinological disorders | 1 (1.6) | 0 (0) | 0.263 | 1 (2.2) | 0 (0) | 0.238 |
Other neurological disorders | 4 (6.5) | 1 (1.3) | 0.105 | 2 (4.4) | 0 (0) | 0.094 |
Polycystic ovary syndrome | 4 (6.5) | 3 (3.9) | 0.493 | 2 (4.4) | 3 (4.8) | 0.924 |
Pulmonary disease | 8 (12.9) | 3 (3.9) | 0.051 | 5 (11.1) | 3 (4.8) | 0.223 |
Variables are presented as count and proportions. Bold p-values represent statistical significance at p < 0.05. Abbreviations: GERD: gastro-esophageal reflux disease; HH: hiatal hernia; IP: in-person modality group; TM: telemedicine modality group.